Contemporary OB/GYN week in review: menstrual health, infertility, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: menstrual health, infertility, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, December 4 - Friday, December 8, 2023), and click each link to read and watch anything you may have missed.
1.) Exploring menstrual health: Insights from the Avon longitudinal study
Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Click here for the full article.
2.) Link between infertility and autism spectrum disorder risk
New research uncovers a connection between infertility and autism spectrum disorder risk, prompting a closer look at perinatal influences and the potential impact of fertility treatments on the developmental trajectory of children.
Click here for the full article.
3.) How plasma biomarkers illuminate brain health in women with HIV
Discoveries from a comprehensive study reveal specific plasma biomarkers that may serve as indicators of neurological well-being in individuals living with HIV, shedding light on potential links to Alzheimer's disease and emphasizing the importance of early detection for improved outcomes.
Click here for the full article.
4.) FDA grants IND clearance to DARE-VVA1 for dyspareunia
Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.
Click here for the full article.
5.) Mediterranean diet linked to improved pregnancy outcomes
A comprehensive meta-analysis scrutinizes the Mediterranean diet's impact on female reproductive health, uncovering compelling evidence that links this nutritional approach to a significant reduction in adverse pregnancy outcomes.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
